Skip to main contentSkip to navigation
Sirius Investors
Abiomed, Inc.

Abiomed, Inc.

ABMD
NASDAQHealthcare

Abiomed, Inc. (ABMD) Investment Research Dashboard

About Abiomed, Inc. (ABMD) stock analysis

Get live ABMD stock price $381.02, comprehensive Abiomed, Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time ABMD stock data and investment insights.

381.02
0.00%Today
Market Cap
17.18B
Volume
15.70M
52W High
381.99
52W Low
219.84

Loading chart data...

Investment Score

TTM (current)
Unavailable

A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.

Score unavailable for this asset.

0-39

Defensive posture

40-54

Mixed / wait for confirmation

55-69

Constructive setup

70-100

Attractive zone

Total Score

Value

Cheapness vs fundamentals and cash generation

Quality

Durability of profitability and balance sheet

Momentum

Price trend strength and persistence

Professional usage: treat the score as a ranking and risk-filtering tool, then confirm with earnings revision trend, competitive positioning, and valuation relative to peers before capital allocation.

Company Overview

Abiomed, Inc. specializes in the creation and distribution of advanced medical technology designed to support or substitute the heart's pumping action in patients suffering from heart failure, while also offering ongoing care for these individuals. I...

Company Information

CEO
Michael Minogue
Sector
Healthcare
Industry
Medical - Devices
Employees
2003

Contact Information

Address
22 CHERRY HILL DR
Country
US

Investment Analysis & Business Insights

Healthcare
Medical - Devices

Investment Highlights

Strong presence in the Healthcare sector with established market position

Growth-oriented company with premium valuation (P/E: 65.4)

Lower volatility stock (Beta: 0.00) may provide portfolio stability

Important Investment Considerations

  • All investments carry risk, including potential loss of principal for Abiomed, Inc. shareholders
  • Market volatility can significantly impact stock price, especially for mid-cap stocks
  • Sector-specific risks in Healthcare may affect company performance
  • Past performance does not guarantee future results for Abiomed, Inc.
  • Investors should consider how Abiomed, Inc. fits within their overall portfolio allocation
  • Premium valuation (P/E: 65.4) requires strong growth to justify

Market Cap

17.18B

P/E Ratio (TTM)

65.36

Beta

0.00

Data Sources & Methodology

Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.

About Healthcare Sector

The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.

Healthcare (1D)

84/100 ⭐⭐⭐⭐⭐

Overall
+1.0%
NYSE
+1.0%
NASDAQ
+1.1%
Sector1D1W1MP/EScore
Energy-0.0%+2.5%+4.6%19.4
89/100⭐⭐⭐⭐⭐
Healthcare+1.0%+1.1%+4.8%23.7
84/100⭐⭐⭐⭐⭐
Industrials+0.3%+1.7%+3.8%30.6
67/100⭐⭐⭐⭐
Financial Services-0.2%-1.3%+3.4%19.3
62/100⭐⭐⭐⭐
Communication Services+0.9%-0.6%+1.4%21.0
59/100⭐⭐⭐⭐
Consumer Defensive+0.1%+1.2%+1.9%29.1
58/100⭐⭐⭐⭐
Real Estate-0.5%+2.1%-2.0%30.1
34/100⭐⭐
Consumer Cyclical+0.7%-1.6%-0.9%46.1
28/100⭐⭐
Technology-1.0%-1.1%-1.0%42.9
27/100⭐⭐
Basic Materials-0.5%-2.7%-1.2%24.6
22/100
Utilities-1.1%-1.1%-6.7%24.3
19/100

Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-08-18.